Clin2
NCT07682948Likely a fitRecruiting

Drug interaction study of UIC202601 and UIC202602 in healthy volunteers

HypertensionDyslipidemia

Part of Heart & circulation, Hormones & metabolism clinical trials.

This trial tests how two experimental drugs, UIC202601 and UIC202602, interact with each other in the body. Healthy volunteers take both drugs to check for side effects and how the body processes them.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
36 people
Ages
19 years to 54 years
Study type
Interventional

Who can take part

  • You are between 19 and 54 years old.
  • You weigh at least 110 pounds (50 kg) for men or 99 pounds (45 kg) for women, and your body mass index (BMI) is between 18 and 30.
  • You are in good general health with no major medical conditions.
  • You agree to use highly effective birth control (like an IUD or abstinence) during the study and for 14 days after the last dose.
  • You have not taken any other experimental drug in the last 6 months, donated blood in the last 8 weeks, or used certain medications in the last month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07162441Recruiting· Phase 1
Drug interaction study in healthy volunteers

This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.

Seoul, Gwanak-gu
NCT07312799Not yet recruiting· Phase 1
How two study drugs interact in healthy adults

This trial tests how two study drugs, AD-2321 and AD-2322, interact with each other in the body and checks if they are safe for healthy adults. Taking part will help researchers learn more about these drugs for future use.

Seoul
NCT07748702Not yet recruiting· Phase 1
Study of a new drug in healthy volunteers

This trial tests a new medicine (CKD-339) in healthy people to see how the body processes it and if it is safe. It is an early-stage study that could help develop a treatment for conditions like high blood pressure or heart problems.

Seoul
NCT07312773Not yet recruiting· Phase 1
Study of three study drugs in healthy adults

This trial tests how three study drugs interact with each other in healthy adults. It may help find safe doses for future treatments.

Seoul
NCT07254481Recruiting· Phase 1
Safety study of VB19055 in healthy volunteers

This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.

Hangzhou
NCT07548957Not yet recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests a new medication (UI087) in healthy volunteers to see how safe it is and how the body processes it, compared to taking three separate medicines together. It's an early-phase trial that may help future patients with a similar treatment option.

Seoul, Gwanak-gu

Hear when a new High blood pressure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.